Form 4: Surgery Partners Executive Jennifer Baldock Receives Restricted Stock Awards

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., reports the acquisition of restricted stock awards on March 4, 2025.

Summary

• Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., filed a Form 4 on March 6, 2025.
• The report details the acquisition of 25,210 shares of common stock at $23.80 per share, representing restricted stock awards (RSAs) that vest in three equal annual installments starting on the first anniversary of the grant date, March 4, 2025.
• Additionally, Baldock acquired 14,285 shares of common stock at $23.80 per share, also representing RSAs, which vest on the first anniversary of the grant date.
• Following these transactions, Baldock beneficially owns 239,667 shares of Surgery Partners, Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of restricted stock awards is a common practice and generally viewed as a positive incentive for executives. There are no indications of negative news or concerns.

Positives

• The grant of restricted stock awards to a key executive aligns her interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The restricted stock awards vest over time, incentivizing the executive to remain with the company and contribute to its long-term success.

Industry Context

Restricted stock awards are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Comparing Surgery Partners' executive compensation structure to companies like HCA Healthcare, Tenet Healthcare, and Universal Health Services would provide a benchmark for assessing the competitiveness and appropriateness of the awards.
• Reviewing the vesting schedules and equity grant sizes relative to industry peers would offer further context.
• Analyzing the overall executive compensation packages, including salary, bonus, and equity, against industry averages would provide a comprehensive comparison.

Stakeholder Impact

• Shareholders may view the grant of restricted stock awards as a positive sign, aligning executive interests with long-term company performance.
• Employees may see this as a positive sign of investment in leadership.

Key Dates

Keywords

Surgery Partners, Jennifer Baldock, restricted stock awards, Form 4, SGRY, beneficial ownership, executive compensation